Retatrutide

Retatrutide

Summary

Retatrutide is one of the most potent research peptides in the metabolic and weight control field: it is studied for its role in fat burning, energy expenditure, and body recomposition. Technically, it is a triple agonist peptide (LY-3437943) that simultaneously activates three key metabolic receptors—GLP-1R, GIPR, and GCGR—a unique combination among incretin agonists that has positioned it as one of the most promising candidates in current research.

What is it being researched for?

  •   Reduction of body weight and body composition
  •   Energy expenditure and fat oxidation
  •   Appetite and satiety regulation
  •   Blood glucose control and insulin sensitivity
  •   Hepatic lipid profile

Cycle and break

Cycle
Continuous until Goal
Break
Not required

Mechanism of action

Triple incretin agonism (GLP-1R / GIPR / GCGR)

Unlike single or dual agonists, Retatrutide simultaneously activates three pathways: GLP-1 receptor (satiety and insulin), GIP receptor (insulin sensitivity), and glucagon receptor (GCGR, which adds energy expenditure and fat mobilization).

Weight reduction and metabolic control

The sum of the three mechanisms translates into a greater effect on body weight and blood glucose than previous agonists in research models.

Energy expenditure and fat metabolism

The glucagon component (GCGR) increases energy expenditure and promotes lipid oxidation, complementing the reduction in food intake mediated by GLP-1 and GIP.

Scientific evidence

Triple agonism: Receptor studies confirm its balanced agonism on the three targets, the basis of its metabolic potency.

Body weight: In a phase 2 clinical trial (Jastreboff et al., NEJM, 2023), Retatrutide produced weight reductions of up to ~24% at 48 weeks, among the largest observed for an incretin agonist.

Energy expenditure: Preclinical models describe increased energy expenditure and improved hepatic lipid profile.

Product use

Due to its triple mechanism and outstanding clinical results, Retatrutide is a top-tier reference material in metabolic and weight control research. At Peptido BioGenetic, we supply it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.

⚠️ Product intended exclusively for research and laboratory use. Not suitable for human or veterinary consumption.

1

Recomendado para la reconstitución

Desde€197,00
2 Cantidad y añadir al carrito

Garantía de Pureza >98.5% Analizado independientemente por espectroscopia y pruebas HPLC. Empaque térmico priority incluido en el envío.

Pureza HPLC
COA disponible
Pago seguro
Envío en frío

Información Clínica

Especificaciones Técnicas

  • Compuesto Retatrutide (LY-3437943)
  • Número CAS 2381089-83-2
  • Fórmula Molecular C221H342N46O68
  • Peso Molecular ~4731,33 g/mol
  • Contenido 20 mg por vial
  • Presentación Polvo liofilizado (vial)
  • Pureza Verificada según estándares de laboratorio europeos · COA disponible bajo solicitud

Almacenamiento

Corto Plazo
por debajo de 4 °C
Largo Plazo
-80 °C
Vida Útil
36 meses
Retatrutide
Desde €197,00

También te puede interesar

TIRZEPATIDE
TIRZEPATIDE
MOTS C
MOTS C
5 AMINO 1MQ
5 AMINO 1MQ